{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:08:54Z","timestamp":1789711734149,"version":"4.0.1"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:p>Health innovation systems continue to face persistent inefficiencies, mistrust, and escalating development costs despite rapid scientific progress. Although patient-engagement is increasingly recognised as essential for patient-centred healthcare innovation, there is limited conceptual and empirical research explaining how patient voices can be systematically embedded within processes and it is relatively unexplored in literature how this influences measurable outcomes such as engagement, collaboration, trust and return-on-investment. This paper addresses this gap through a hypothesis and conceptual analysis informed by interdisciplinary literature, industry reports and case-based evidence examining the integration of patient voices across health innovation processes and posits that authentic content functions as an effective and scalable mechanism for embedding patient voices across multiple stages of the health innovation lifecycle. The emergence of artificial intelligence also offers the potential to increase and amplify diffusions from authentic content and facilitate mass personalisation of patient voices across innovation lifecycles but, even without this, authentic content is proposed as a strategic priority and a high-fidelity mechanism for multi-level stakeholder engagement that may be associated with enhanced patient access and stronger financial outcomes. The timing of authentic content deployment is also hypothesised to be an important determinant of its potential impact, with earlier integration proposed to produce a \u201cleftward shift\u201d in the cumulative trajectory of stakeholder-engagement and value-creation and an acceleration of development that, if empirically supported, may be associated with longer periods of effective commercial market exclusivity, faster patient access to medicines, and more efficient provision of access through greater scalability. If validated through future empirical research and academic rigour, authentic content may represent a scalable and measurable approach for embedding patient voices as a strategic driver of engagement, innovation efficiency, and patient-centred value creation in health innovation systems.<\/jats:p>","DOI":"10.3389\/frhs.2026.1833920","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:00Z","timestamp":1789709880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Authentic content as an effective mechanism for embedding patient voices in health innovation: a hypothesis and conceptual framework"],"prefix":"10.3389","volume":"6","author":[{"given":"Rohin","family":"Malhotra","sequence":"first","affiliation":[{"name":"Boofel Enterprises","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","volume-title":"Pharmaceutical Innovation in Healthcare: Exploring Open Innovation Models and Biotechnology","author":"Fernandes","year":"2024"},{"key":"B2","author":"Jeon","year":"2022"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.4324\/9781003330271","volume-title":"New Drugs, Fair Prices: Managing the Pharmaceutical Innovation Ecosystem for Sustainable and Affordable new Medicines","author":"Smith","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1060028018765159","article-title":"Cost of prescription drug\u2013related morbidity and mortality","volume":"52","author":"Watanabe","year":"2018","journal-title":"Ann Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"B6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/17460441.2015.1037271","article-title":"Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement","volume":"10","author":"Allarakhia","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"B7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/2168479015580384","article-title":"Partnering with patients in the development and lifecycle of medicines: a call for action","volume":"49","author":"Hoos","year":"2015","journal-title":"Ther Innov Regul Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40900-022-00364-8","article-title":"Practices of patient engagement in drug development: a systematic scoping review","volume":"8","author":"Zvonareva","year":"2022","journal-title":"Res Involv Engagem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/2168479017706405","article-title":"Improving patient Involvement in medicines research and development: a practical roadmap","volume":"51","author":"Geissler","year":"2017","journal-title":"Ther Innov Regul Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"f2614","DOI":"10.1136\/bmj.f2614","article-title":"Let the patient revolution begin","volume":"346","author":"Richards","year":"2013","journal-title":"Br Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1274688","DOI":"10.3389\/fmed.2024.1274688","article-title":"Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators","volume":"11","author":"Cimiano","year":"2024","journal-title":"Front Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-2923.2009.03328.x","article-title":"Medical students benefit from learning about patient safety in an interprofessional team","volume":"43","author":"Anderson","year":"2009","journal-title":"Med Educ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1197\/j.aem.2004.08.003","article-title":"See one, do one, teach one: advanced technology in medical education","volume":"11","author":"Vozenilek","year":"2004","journal-title":"Acad Emerg Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/0272989X12463266","article-title":"All stories are not created equal: why the type of story matters in patient education","volume":"93","author":"Shaffer","year":"2013","journal-title":"Patient Educ Couns"},{"key":"B15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/1090198106291963","article-title":"Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview","volume":"34","author":"Hinyard","year":"2007","journal-title":"Health Educ Behav"},{"key":"B16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1468-0009.2012.00662.x","article-title":"Health and illness in a connected world: how might sharing experiences on the internet affect people\u2019s health?","volume":"90","author":"Ziebland","year":"2012","journal-title":"Milbank Q"},{"key":"B17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/COPD.S148685","article-title":"Narrative medicine to improve the management and quality of life of patients with COPD: the first experience applying parallel chart in Italy","volume":"13","author":"Banfi","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.33590\/emjinnov\/10313381","article-title":"A transition from disease-centred to goal-directed individualised care of patients with multiple morbidities: a journey to goal-orientated patient healthcare","volume":"2","author":"Rygiel","year":"2019","journal-title":"Innovations"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11606-021-07104-w","article-title":"Understanding the influence and impact of stakeholder engagement in patient-centered outcomes research: a qualitative study","volume":"37","author":"Maurer","year":"2022","journal-title":"J Gen Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"23743735221125439","DOI":"10.1177\/23743735221125439","article-title":"Impact of patient engagement on healthcare quality: a scoping review","volume":"9","author":"Marzban","year":"2022","journal-title":"J Patient Exp"},{"key":"B21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s11606-023-08500-0","article-title":"The role of human-centered design in healthcare innovation: a digital health equity case study","volume":"39","author":"Levander","year":"2024","journal-title":"J Gen Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/HMR.0000000000000386","article-title":"Learning from patients: the impact of using patients\u2019 narratives on patient experience scores","volume":"49","author":"Nembhard","year":"2024","journal-title":"Health Care Manage Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1355819619888675","article-title":"How do frontline staff use patient experience data for service improvement? Findings from an ethnographic case study evaluation","volume":"25","author":"Locock","year":"2020","journal-title":"J Health Serv Res Policy"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/0142159X.2016.1210109","article-title":"Does hearing the patient perspective improve consultation skills? An exploratory randomised controlled trial in medical undergraduate education","volume":"38","author":"Snow","year":"2016","journal-title":"Med Educ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1370\/afm.624","article-title":"Jazz and the \u2018art\u2019of medicine: improvisation in the medical encounter","volume":"5","author":"Haidet","year":"2007","journal-title":"Ann Family Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pec.2006.05.002","article-title":"Patient involvement in treatment decision-making: the case for a broader conceptual framework","volume":"63","author":"Entwistle","year":"2006","journal-title":"Patient Educ Couns"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1177\/2374373520958340","article-title":"Patient stories can make a difference in patient-centered research design","volume":"7","author":"Novak","year":"2020","journal-title":"J Patient Exp"},{"key":"B28","volume-title":"A New Model for Academic Science Communication: Leveraging YouTube and TikTok to Enhance Public Engagement","author":"Thornton","year":"2025"},{"key":"B29","year":""},{"key":"B30","doi-asserted-by":"publisher","first-page":"e009001","DOI":"10.1161\/CIRCOUTCOMES.122.009001","article-title":"Incidence of timely outpatient follow-up care after emergency department encounters for acute heart failure","volume":"15","author":"Kilaru","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B31","year":"2025"},{"key":"B32","year":""},{"key":"B33","year":"2023"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5837\/bjc.2022.005","article-title":"Heart failure care pathways: the power of collaboration and marginal gains","volume":"29","author":"Barton","year":"2022","journal-title":"Br J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.5837\/bjc.2019.s04","article-title":"Initial experience of introducing sacubitril\/valsartan in a UK heart failure service","volume":"26","author":"Crawley","year":"2019","journal-title":"Br J Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e002933","DOI":"10.1136\/openhrt-2024-002933","article-title":"Effect of optimisation to contemporary HFrEF medical therapy with sacubitril\/valsartan (entresto) and dapaglifloziN on left ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) imaging: the ENVI study","volume":"11","author":"Zheng","year":"2024","journal-title":"Open Heart"},{"key":"B37","year":"2024"},{"key":"B38","year":""},{"key":"B39","year":"2024"},{"key":"B40","author":"Whitington","year":"2016"},{"key":"B41","year":"2016"},{"key":"B42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.sheji.2024.07.002","article-title":"Understanding medical technology innovation in low-and middle-income countries: factors, impact, and a model proposal","volume":"10","author":"Dutta","year":"2024","journal-title":"She Ji"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"B44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s43441-025-00899-4","article-title":"Insights informing strategies for optimizing the collection of clinical trial data","volume":"60","author":"Getz","year":"2026","journal-title":"Ther Innov Regul Sci"},{"key":"B45","year":""},{"key":"B46","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/2168479015578154","article-title":"Expanded access programs: ethical and practical considerations for biopharmaceutical sponsors","volume":"49","author":"Klopfenstein","year":"2015","journal-title":"Ther Innov Regul Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2147\/PPA.S81975","article-title":"Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment","volume":"9","author":"Tzelepis","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"B48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1162\/rest_a_00987","article-title":"Patents, data exclusivity, and the development of new drugs","volume":"104","author":"Gaessler","year":"2022","journal-title":"Rev Econ Stat"},{"key":"B49","doi-asserted-by":"publisher","first-page":"03026","DOI":"10.7189\/jogh.15.03026","article-title":"Stakeholder engagement champions: a locally-driven model for building impactful and sustainable relationships in global health research","volume":"15","author":"Jackson","year":"2025","journal-title":"J Glob Health"},{"key":"B50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4324\/9780203710753-35","article-title":"Diffusion of innovations 1","volume-title":"An Integrated Approach to Communication Theory and Research","author":"Rogers","year":"2019"},{"key":"B51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1377\/hlthaff.2017.1104","article-title":"Diffusion of innovations theory, principles, and practice","volume":"37","author":"Dearing","year":"2018","journal-title":"Health Aff"},{"key":"B52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12967-016-0838-4","article-title":"Changing R&D models in research-based pharmaceutical companies","volume":"14","author":"Schuhmacher","year":"2016","journal-title":"J Transl Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.jik.2024.100620","article-title":"The challenge of measuring innovation types: a systematic literature review","volume":"9","author":"Stundziene","year":"2024","journal-title":"J Innov Knowl"},{"key":"B54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.0887-378X.2004.00325.x","article-title":"Diffusion of innovations in service organizations: systematic review and recommendations","volume":"82","author":"Greenhalgh","year":"2004","journal-title":"Milbank Q"},{"key":"B55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"key":"B57","volume-title":"Quality Assurance Management: A Comprehensive Overview of Real-World Applications for High Risk Specialties","author":"De Lanerolle","year":"2024"},{"key":"B58","volume-title":"Strategic Management: A Stakeholder Approach","author":"Freeman","year":"1984"},{"key":"B59","volume-title":"This is Service Design Doing: Applying Service Design Thinking in the Real World","author":"Stickdorn","year":"2018"},{"key":"B60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21606\/servdes2010.23","article-title":"Transformative services and transformation design","volume":"5","author":"Sangiorgi","year":"2010","journal-title":"Int J Des"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/14719037.2014.930505","article-title":"A systematic review of co-creation and co-production: embarking on the social innovation journey","volume":"17","author":"Voorberg","year":"2015","journal-title":"Public Manag Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/01944366908977225","article-title":"A ladder of citizen participation","volume":"35","author":"Arnstein","year":"1969","journal-title":"J Am Inst Plann"},{"key":"B63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.healthpol.2005.05.008","article-title":"The snakes and ladders of user involvement: moving beyond arnstein","volume":"76","author":"Tritter","year":"2006","journal-title":"Health Policy"},{"key":"B64","author":"Foster","year":"2025"},{"key":"B65","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1002\/jcph.2134","article-title":"Natural history and real-world data in rare diseases: applications, limitations, and future perspectives","volume":"62","author":"Liu","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/hex.12951","article-title":"Evaluating the \u201creturn on patient engagement initiatives\u201d in medicines research and development: a literature review","volume":"23","author":"Vat","year":"2020","journal-title":"Health Expect"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/03007995.2025.2537888","article-title":"From insight to impact: a qualitative study on pharmaceutical industry professionals\u2019 perceptions of the value of patient engagement","volume":"41","author":"Auwal","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"B68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13063-018-2578-7","article-title":"Patient-centered recruitment and retention for a randomized controlled study","volume":"19","author":"Chhatre","year":"2018","journal-title":"Trials"},{"key":"B69","volume-title":"The Innovation Imperative: The Future of Drug Development. Part I: Research Methods and Findings","year":"2018"},{"key":"B70","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s43441-025-00751-9","article-title":"Promoting diversity through an understanding of barriers and drivers for inclusive clinical trials","volume":"59","author":"De Bruin","year":"2025","journal-title":"Ther Innov Regul Sci"},{"key":"B71","first-page":"13","article-title":"Measuring adoption and value of patient engagement","volume":"26","author":"Getz","year":"2017","journal-title":"Appl Clin Trials"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-017-0264-6","article-title":"Making patient engagement a reality","volume":"11","author":"Pushparajah","year":"2018","journal-title":"Patient"},{"key":"B73","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/2168479017716715","article-title":"Assessing the financial value of patient engagement: a quantitative approach from CTTI\u2019s patient groups and clinical trials project","volume":"52","author":"Levitan","year":"2018","journal-title":"Ther Innov Regul Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/2168479016632271","article-title":"The impact of protocol amendments on clinical trial performance and cost","volume":"50","author":"Getz","year":"2016","journal-title":"Ther Innov Regul Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1090198104263660","article-title":"Health promotion by social cognitive means","volume":"31","author":"Bandura","year":"2004","journal-title":"Health Education Behavior"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1001\/jama.286.15.1897","article-title":"Narrative medicine: a model for empathy, reflection, profession, and trust","volume":"286","author":"Charon","year":"2001","journal-title":"JAMA"},{"key":"B77","first-page":"10","article-title":"Amplifying patient voices in protocol design","volume":"30","author":"Getz","year":"2021","journal-title":"Appl Clin Trials"},{"key":"B78","volume-title":"Impact of Integrated and Patient-centric clinical Development on Phase I-III Cycle Times","year":"2025"},{"key":"B79","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s43441-019-00034-0","article-title":"Measuring the impact of patient engagement and patient centricity in clinical research and development","volume":"54","author":"Stergiopoulos","year":"2020","journal-title":"Therapeutic Innovation Regulatory Science"},{"key":"B80","first-page":"13","article-title":"Bridging the valley of death: improving the commercialisation of research","volume":"2013","author":"Parliament","year":"2012","journal-title":"Eighth Report of Session"},{"key":"B81","unstructured":"Bozic\n              MK\n            \n          \n          University of Southern California\n          The impact of FDA patient-focused drug development (PFDD) on US drug development strategies: a survey of views from pharmaceutical product companies\n          \n          2023"},{"key":"B82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1037\/bul0000473","article-title":"Ignored, dismissed, and minimized: understanding the harmful consequences of invalidation in health care\u2014a systematic meta-synthesis of qualitative research","volume":"151","author":"Bontempo","year":"2025","journal-title":"Psychol Bull"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1399947","DOI":"10.3389\/fmed.2024.1399947","article-title":"A decade of collaboration in medicines regulation: healthcare professionals engaging with the European medicines agency","volume":"11","author":"Silva","year":"2024","journal-title":"Front Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0265712","DOI":"10.1371\/journal.pone.0265712","article-title":"A framework for assessing the impact of accelerated approval","volume":"17","author":"Gould","year":"2022","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.18553\/jmcp.2017.23.10.1078","article-title":"Patient-centered drug approval: the role of patient advocacy in the drug approval process","volume":"23","author":"Mattingly","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4172\/2157-7633.1000334","article-title":"The limitations of QALY: a literature review","volume":"6","author":"Pettitt","year":"2016","journal-title":"J Stem Cell Res Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1017\/S0266462320002214","article-title":"Evaluation of the impact of patient input in health technology assessments at NICE","volume":"37","author":"Livingstone","year":"2021","journal-title":"Int J Technol Assess Health Care"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1186\/s12913-022-08437-w","article-title":"Impact of managed entry agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries","volume":"22","author":"Efthymiadou","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"750742","DOI":"10.3389\/fphar.2021.750742","article-title":"Assessing the value of nusinersen for spinal muscular atrophy: a comparative analysis of reimbursement submission and appraisal in European countries","volume":"12","author":"Blonda","year":"2022","journal-title":"Front Pharmacol"},{"key":"B90","volume-title":"Same Time Decisions on Licensing and Value: What Pharmaceutical Companies Need to Know","year":"2025"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1017\/S0266462325000182","article-title":"Patient engagement for the development of equity-focused health technology assessment (HTA) recommendations: a case study of two Canadian HTA organizations","volume":"41","author":"Simeon","year":"2025","journal-title":"Int J Technol Assess Health Care"},{"key":"B92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s43441-025-00770-6","article-title":"Patient engagement and patient experience data in regulatory review and health technology assessment: where are we today?","volume":"59","author":"Bertelsen","year":"2025","journal-title":"Ther Innov Regul Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaad.2024.04.026","article-title":"Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay registry","volume":"91","author":"Zhang","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e009415","DOI":"10.1136\/bmjopen-2015-009415","article-title":"Does the engagement of clinicians and organisations in research improve healthcare performance: a three-stage review","volume":"5","author":"Boaz","year":"2015","journal-title":"BMJ Open"},{"key":"B95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/admsci14070148","article-title":"Exploring purpose-driven leadership: theoretical foundations, mechanisms, and impacts in organizational context","volume":"14","author":"Ribeiro","year":"2024","journal-title":"Adm Sci"},{"key":"B96","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clnesp.2022.11.012","article-title":"In their shoes: health care professionals walking a day in the life of patients with short bowel syndrome & intestinal failure","volume":"53","author":"Twist","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"B97","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40900-021-00305-x","article-title":"The use of digital storytelling of patients\u2019 stories as an approach to translating knowledge: a scoping review","volume":"7","author":"Park","year":"2021","journal-title":"Res Involv Engagem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3389\/fpsyg.2018.02124","article-title":"Walking in a patient\u2019s shoes: an evaluation study of immersive learning using a digital training intervention","volume":"9","author":"Halton","year":"2018","journal-title":"Front Psychol"},{"key":"B99","year":"2019"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e50527","DOI":"10.2196\/50527","article-title":"A patient-driven mobile health innovation in cystic fibrosis care: comparative cross-case study","volume":"26","author":"Mazzocato","year":"2024","journal-title":"J Med Internet Res"},{"key":"B101","volume-title":"Factors Causing Commercial Leaders in US Multinational Pharmaceutical Businesses to Change Companies","author":"Britting","year":"2022"},{"key":"B102","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/13561820.2024.2334959","article-title":"The impact of using an authentic patient video on health professional students\u2019 attitudes toward interprofessional and person-centered care","volume":"38","author":"Nissen","year":"2024","journal-title":"J Interprof Care"},{"key":"B103","year":"2020"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40271-024-00713-7","article-title":"Measuring and demonstrating the value of patient engagement across the medicines lifecycle: a patient engagement impact measurement framework","volume":"18","author":"Klein","year":"2024","journal-title":"Patient"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e35419","DOI":"10.1016\/j.heliyon.2024.e35419","article-title":"Project management in healthcare: an examination of organizational competence","volume":"10","author":"Cristina","year":"2024","journal-title":"Heliyon"},{"key":"B106","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MLR.0000000000001728","article-title":"Caregiver engagement enhances outcomes among randomized control trials of transitional care interventions: a systematic review and meta-analysis","volume":"60","author":"Levoy","year":"2022","journal-title":"Med Care"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3332\/ecancer.2022.1473","article-title":"Burnout among physicians and caregivers in oncology: the Moroccan experience","volume":"16","author":"Benhaddouch","year":"2022","journal-title":"Ecancermedicalscience"},{"key":"B108","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1365-2125.2012.04366.x","article-title":"How clinical decisions are made","volume":"74","author":"Bate","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/hex.12893","article-title":"The role of patients and carers in diffusing a health-care innovation: a case study of \u201cmy medication passport\u201d","volume":"22","author":"Barber","year":"2019","journal-title":"Health Expect"},{"key":"B110","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12913-024-11138-1","article-title":"The effectiveness of visual-based interventions on health literacy in health care: a systematic review and meta-analysis","volume":"24","author":"Galmarini","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"B111","year":"2024"},{"key":"B112","doi-asserted-by":"publisher","first-page":"770","DOI":"10.18553\/jmcp.2019.18443","article-title":"Patient support program increased medication adherence with lower total health care costs despite increased drug spending","volume":"25","author":"Brixner","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"B113","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1369-7625.2010.00620.x","article-title":"Exploring the influence of service user involvement on health and social care services for cancer","volume":"14","author":"Attree","year":"2011","journal-title":"Health Expect"},{"key":"B114","article-title":"Measuring the ROI of SPP adherence programs","volume":"45","author":"Anbil","year":"2025","journal-title":"Pharm Exec"},{"key":"B115","volume-title":"2025 Edelman Trust Barometer: Trust and Health","year":"2025"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1536753","DOI":"10.3389\/fpubh.2025.1536753","article-title":"Stakeholders\u2019 engagement for improved health outcomes: a research brief to design a tool for better communication and participation","volume":"13","author":"Pellegrini","year":"2025","journal-title":"Front Public Health"},{"key":"B117","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1108\/JHOM-07-2023-0207","article-title":". trust in embedding co-design for innovation and change: considering the role of senior leaders and managers","volume":"38","author":"Bedenik","year":"2024","journal-title":"J Health Organ Manag"},{"key":"B118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/08901171251365366","article-title":"Storytelling for health promotion: a scoping review","volume":"40","author":"Nagarkar","year":"2026","journal-title":"Am J Health Promot"},{"key":"B119","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-154-2-201101180-00004","article-title":"Culturally appropriate storytelling to improve blood pressure: a randomized trial","volume":"154","author":"Houston","year":"2011","journal-title":"Ann Intern Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/0145721717713317","article-title":"Pilot feasibility study of a digital storytelling intervention for immigrant and refugee adults with diabetes","volume":"43","author":"Wieland","year":"2017","journal-title":"Diabetes Educ"},{"key":"B121","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/08870446.2022.2063863","article-title":"Experiences of successful physical activity maintenance among adults with type 2 diabetes: a theory-based qualitative study","volume":"39","author":"Blicher-Hansen","year":"2024","journal-title":"Psychology Health"},{"key":"B122","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","article-title":"Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life","volume":"61","author":"Religioni","year":"2025","journal-title":"Medicina"},{"key":"B123","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12904-023-01319-w","article-title":"The role of patients\u2019 stories in medicine: a systematic scoping review","volume":"22","author":"Quah","year":"2023","journal-title":"BMC Palliat Care"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2147\/PPA.S253918","article-title":"An evaluation of the video narrative technique on the self-efficacy of medication understanding and use among post-stroke patients: a randomized-controlled trial","volume":"14","author":"Appalasamy","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"B125","year":""},{"key":"B126","year":""},{"key":"B127","year":"2022"},{"key":"B128","doi-asserted-by":"publisher","first-page":"440","DOI":"10.37880\/cumuiibf.1429844","article-title":"Healthcare Marketing Evolution: A Comprehensive Exploration of New-Age Strategies and Patient-Centric Paradigms.","volume":"25","author":"\u015eenyapar","year":"2024","journal-title":"Cumhuriyet \u00dcniversitesi \u0130ktisadi ve \u0130dari Bilimler Dergisi"},{"key":"B129","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/19322968221113838","article-title":"The influence of digital affinity on the continuous glucose monitoring system choice by people with type 1 diabetes","volume":"18","author":"Kinzel","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","article-title":"Patient engagement in research: a systematic review","volume":"14","author":"Domecq","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.jpha.2025.101248","article-title":"The future of pharmaceuticals: artificial intelligence in drug discovery and development","volume":"15","author":"Fu","year":"2025","journal-title":"J Pharm Anal"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e75849","DOI":"10.2196\/75849","article-title":"Harm reduction strategies for thoughtful use of large language models in the medical domain: perspectives for patients and clinicians","volume":"27","author":"Mo\u00ebll","year":"2025","journal-title":"J Med Internet Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1547166","DOI":"10.3389\/fimag.2025.1547166","article-title":"Continuous patient monitoring with AI: real-time analysis of video in hospital care settings","volume":"4","author":"Gabriel","year":"2025","journal-title":"Front Imaging"},{"key":"B134","year":"2025"},{"key":"B135","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e53505","DOI":"10.2196\/53505","article-title":"The dual nature of AI in information dissemination: ethical considerations","volume":"3","author":"Germani","year":"2024","journal-title":"Jmir Ai"},{"key":"B137","doi-asserted-by":"publisher","first-page":"18994","DOI":"10.1038\/s41598-024-70073-7","article-title":"Innovation and challenges of artificial intelligence technology in personalized healthcare","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e63377","DOI":"10.2196\/63377","article-title":"Problems and barriers related to the use of AI-based clinical decision support systems: interview study","volume":"27","author":"Giebel","year":"2025","journal-title":"J Med Internet Res"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1833920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:38:06Z","timestamp":1789709886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1833920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":138,"alternative-id":["10.3389\/frhs.2026.1833920"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2026.1833920","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1833920"}}